Planned drug holidays during treatment with lenvatinib for radioiodine-refractory differentiated thyroid cancer: a retrospective study

Matsuyama, C; Enokida, T; Ueda, Y; Suzuki, S; Fujisawa, T; Ito, K; Okano, S; Tahara, M

Tahara, M (通讯作者),Natl Canc Ctr Hosp East, Dept Head & Neck Med Oncol, Kashiwa, Japan.

FRONTIERS IN ONCOLOGY, 2023; 13 ():

Abstract

Background In the phase 3 SELECT study, lenvatinib significantly improved prognostic outcomes vs. placebo in patients with radioiodine-refractory diff......

Full Text Link